SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-18-037041
Filing Date
2018-05-31
Accepted
2018-05-31 11:17:35
Documents
1
Group Members
LEERINK REVELATION HEALTHCARE FUND I GP, L.P.LEERINK REVELATION HEALTHCARE FUND I GP, LLCSCOTT HALSTEDTIMOTHY A.G. GERHOLDZACHARY SCOTT

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-14614_1sc13g.htm SC 13G 218730
  Complete submission text file 0001104659-18-037041.txt   220426
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Subject) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86112 | Film No.: 18870493
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 SPEAR STREET 16TH FLOOR SAN FRANCISCO CA 29105
Business Address 201 SPEAR STREET 16TH FLOOR SAN FRANCISCO CA 29105 415-706-8852
LEERINK REVELATION HEALTHCARE FUND I, L.P. (Filed by) CIK: 0001612448 (see all company filings)

IRS No.: 611729043 | State of Incorp.: DE
Type: SC 13G